Advertisement

chronic-disease

Semaglutide and phentermine-topiramate are effective weight reducing medications

1. GLP-1 receptor agonists, such as semaglutide, and phentermine-topiramate were shown to cause the greatest percent decrease in body weight. 2. GLP-1 receptor agonists, phentermine-topiramate, and naltrexone-bupropion were also associated with increased adverse effects. Evidence Rating Level: 1 (Excellent) Study Rundown: Over two-thirds of Americans are considered to be in the overweight or obese body-mass […]

Read More

Angiotensin II receptor type 2 and 4-stimulating antihypertensives associated with reduced long-term cognitive impairment compared to receptor inhibitors

1. This secondary analysis of the SPRINT cohort study demonstrated that type 2 and 4 angiotensin II receptor (AT2R/AT4R)-stimulating antihypertensives decreased the risk of amnestic mild cognitive impairment or probable dementia by approximately 25% compared to AT2R/AT4R-inhibiting antihypertensives. Evidence Rating Level: 2 (Good) Study Rundown: Hypertension is a well-known, highly prevalent, modifiable risk for dementia. […]

Read More

Knee extensor muscle weakness may be a risk factor for osteoarthritis

1. Low quality evidence demonstrates that knee extensor muscle weakness increased the odds of symptomatic and radiographic knee osteoarthritis in men and women. 2. In women with a previous knee injury, low quality evidence shows no association between knee extensor muscle weakness and symptomatic and radiographic tibiofemoral osteoarthritis. Evidence Rating Level: 2 (Good) Knee osteoarthritis […]

Read More

Endovascular thrombectomy 6 to 24-hours after anterior circulation stroke significantly reduces disability rates

1. Patients in the thrombectomy group reported a greater independence in daily living compared to those receiving best medical therapy alone. 2. 90-day mortality did not differ between the thrombectomy and best medical therapy groups. Evidence Rating Level: 1 (Excellent) Study Rundown: There exists extensive evidence around the use of mechanical thrombectomy for patients with […]

Read More

mRNA-1273 vaccine reduces risk of Covid-19-related outcomes compared to BNT162b2 in U.S. veterans

1. The mRNA-1273 vaccine was shown to reduce the absolute risk of Covid-19-related outcomes in U.S. veterans compared to BNT162b2 vaccine. 2. Both mRNA-1273 and BNT162b2 vaccines were shown to reduce the absolute risk of Covid-19-related outcomes in U.S. veterans. Evidence Rating Level: 2 (Good)      Study Rundown: To help combat the SARS-CoV-2 (Covid-19) pandemic, messenger […]

Read More

Extreme prematurity associated with increased prevalence of visual and ocular deficits in young adults

1. Extreme prematurity was associated with an increased prevalence of visual and ocular deficits, suggesting children born extremely preterm may have residual ophthalmic sequelae persisting into adulthood. 2. These findings emphasized the need for screening and management of any deficits as they evolve long-term at a population-level. Evidence Rating Level: 2 (Good) Study Rundown: Although […]

Read More

Hybrid closed-loop therapy improves glycemic control for children with Type 1 Diabetes

1. In very young children with type 1 diabetes, a hybrid closed-loop therapy provided significantly improved glycemic children. 2. The hybrid closed-loop therapy did not significantly increase the time spent in hypoglycemia in very young children with type 1 diabetes. Evidence Rating Level: 1 (Excellent) Study Rundown: In very young children, managing Type 1 Diabetes […]

Read More

Intracranial efficacy of alectinib in ALK-positive NSCLC patients with CNS metastases

1. Treatment with alectinib reduced CNS lesion sizes and significantly improved symptoms, ECOG performance scores and requirements for mannitol and corticosteroids in patients with metastases from non-small cell lung cancer. Evidence Level Rating: 2 (Good) Central nervous system metastases are highly prevalent in patients with ALK gene mutations driving advanced non-small cell lung cancer despite […]

Read More

For latest news and updates
Email-id is invalid